- The paradox of immunotherapy in NASH-HCCPeng, Yao; Wong, Chi Chun; Yu, Jun*Signal Transduction and Targeted Therapy, 2021, 6(1): 228.被引 6
- Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: a population-based studyLee, S.; Zhou, J.; Lakhani, I; Yang, L.; Liu, T.; Zhang, Y.; Xia, Y.; Wong, W. T.; Chan, E. W. Y.; Wong, I. C. K.; Tse, G.; Zhang, Q.被引 2
- Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitorsLili, LI; Jiajian, YeMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2020, 99(37): e21788.被引 2
期刊论文
Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses
5被引14阅读
